Biomax Provides AI-Based Semantic Search Platform AILANI and Supports COVID-19 International Efforts

Biomax InformaticsThe bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful search for drugs and suitable vaccinesagainst COVID-19 infections.

Biomax experts have pre-configured AILANI forthe specific needs of researchers in the field of COVID-19 and integrated publicly available literature, data and knowledge.Using AILANI scientists get faster insight in existing knowledge, discover previously unknown associationsand areable to takebetter research decisions.The new search platform is accessible at https://ailani.ai.

Biomax also supports international efforts to collect knowledge with a special text mining system. In this context Biomaxispartner of PREPARE, a platform for European Preparedness against (Re-)Emerging Epidemics,and member of the COVID-19 Disease Map Community, a European program that has beenset up to share resources and best practices to develop a disease map for COVID-19andSARS-CoV-2.

Biomax's expertise in electronic case reporting (eCRF) and the established data integration system BioXM additionally enables the design of an open, comprehensive information network for the collection, management and analysis of data on the COVID-19 epidemic, clinical disease progression or rehabilitation, tohelp physicians find the best treatment for their individual patients.

For further information, please visit:
http://www.biomax.com

About Biomax Informatics

Biomax Informatics provides services and software solutions for efficient decision making and knowledge management at the intersection of life sciences, healthcare and information technologies. Biomax facilitates digital transformation within biotech, pharma,agriculture, food and chemical industries as well as research institutes.

The companylooks back on 20 years of experience and currently employs around 50 people - including numerous life scientists, data scientists and software developers with a scientific background.

Founded in 1997, Biomax Informatics is ISO9001 and ISO27001 certified and is headquartered in Planegg near Munich, Germany.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...